Overview
Ritesh Rathore is a Hematologist practicing medicine in Providence, Rhode Island.
Dr. Rathore is highly rated in 23 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Pleuropulmonary Blastoma, Familial Pancreatic Cancer, Bone Marrow Transplant, and Colonoscopy.
He is actively involved in clinical research, co-authoring 9 peer reviewed articles and participating in 4 clinical trials.
Specialties
Licenses
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- MANAGED MEDICAID PLAN
- MEDICARE ASSISTANCE PROGRAM
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- INSURANCE PLAN
- MEDICARE MAPD
- HMO
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
825 Chalkstone Ave, Providence, RI 02908
50 Maude St, Providence, RI 02908
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
4 Clinical Trials
Rhode Island Hospital
Adam Olszewski is a Hematologist practicing medicine in Providence, Rhode Island. Dr. Olszewski is highly rated in 26 conditions, according to our data. His clinical expertise encompasses B-Cell Lymphoma, Marginal Zone Lymphoma (MZL), Non-Hodgkin Lymphoma, Splenectomy, and Bone Marrow Aspiration.
Miriam Hospital
Howard Safran is a Hematologist practicing medicine in Providence, Rhode Island. Dr. Safran is highly rated in 28 conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Gastroesophageal Junction Cancer, Colorectal Cancer, Familial Pancreatic Cancer, and Pancreaticoduodenectomy.
Dana-Farber Cancer Institute
Rachael Grace is a Hematologist and an Oncologist practicing medicine in Boston, Massachusetts. Dr. Grace is highly rated in 13 conditions, according to our data. Her clinical expertise encompasses Pyruvate Kinase Deficiency, Immune Thrombocytopenic Purpura (ITP), Hemolytic Anemia, Splenectomy, and Gallbladder Removal.
Frequently Asked Questions about Dr. Ritesh Rathore
How do I make an appointment with Dr. Ritesh Rathore?
You can book an appointment with Dr. Ritesh Rathore by calling their office at 401-456-2077. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Ritesh Rathore a top-rated expert for Lung Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Ritesh Rathore is classified as an Distinguished expert for Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Ritesh Rathore specialize in?
While Dr. Ritesh Rathore is a Hematology, they have specific expertise in Lung Cancer, Pleuropulmonary Blastoma, and Familial Pancreatic Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.
Does Dr. Ritesh Rathore participate in research or clinical trials?
Yes. Dr. Ritesh Rathore has published 9 articles and abstracts on conditions like Lung Cancer. You can view a list of Dr. Ritesh Rathore's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Ritesh Rathore accept my insurance?
Dr. Ritesh Rathore accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 401-456-2077 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Familial Pancreatic CancerDr. Rathore isDistinguished. Learn about Familial Pancreatic Cancer.
- Lung CancerDr. Rathore isDistinguished. Learn about Lung Cancer.
- Pleuropulmonary BlastomaDr. Rathore isDistinguished. Learn about Pleuropulmonary Blastoma.
- Pseudomyxoma PeritoneiDr. Rathore isDistinguished. Learn about Pseudomyxoma Peritonei.
- Advanced
- ALK-Positive Non-Small Cell Lung Cancer
- AnemiaDr. Rathore isAdvanced. Learn about Anemia.
- Childhood Acute Myeloid LeukemiaDr. Rathore isAdvanced. Learn about Childhood Acute Myeloid Leukemia.
- Childhood Iron Deficiency AnemiaDr. Rathore isAdvanced. Learn about Childhood Iron Deficiency Anemia.
- Chronic B-Cell Leukemia (CBCL)Dr. Rathore isAdvanced. Learn about Chronic B-Cell Leukemia (CBCL).
- Chronic Lymphocytic Leukemia (CLL)Dr. Rathore isAdvanced. Learn about Chronic Lymphocytic Leukemia (CLL).
- Experienced
- Acute Mountain SicknessDr. Rathore isExperienced. Learn about Acute Mountain Sickness.
- Adult Immune ThrombocytopeniaDr. Rathore isExperienced. Learn about Adult Immune Thrombocytopenia.
- Adult Soft Tissue SarcomaDr. Rathore isExperienced. Learn about Adult Soft Tissue Sarcoma.
- AgranulocytosisDr. Rathore isExperienced. Learn about Agranulocytosis.
- Alveolar Soft Part SarcomaDr. Rathore isExperienced. Learn about Alveolar Soft Part Sarcoma.
- AngiosarcomaDr. Rathore isExperienced. Learn about Angiosarcoma.